Targeting an energy sensor to treat diabetes
- 4 August 2017
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 357 (6350) , 455-456
Abstract
New activators of AMPK have beneficial effects in type 2 diabetes mellitusKeywords
This publication has 14 references indexed in Scilit:
- Choreography of AMPK activationCell Research, 2014
- Structural basis of AMPK regulation by small molecule activatorsNature Communications, 2013
- Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metforminNature Medicine, 2013
- The Ancient Drug Salicylate Directly Activates AMP-Activated Protein KinaseScience, 2012
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJournal of Clinical Investigation, 2010
- Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein KinaseJournal of Biological Chemistry, 2007
- AMP-Activated Protein Kinase in the HeartCirculation Research, 2007
- Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndromeCell Metabolism, 2006
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001